CNMD
Price
$47.64
Change
-$1.61 (-3.27%)
Updated
Jul 18 closing price
Capitalization
2.43B
9 days until earnings call
IART
Price
$11.13
Change
-$0.85 (-7.10%)
Updated
Jul 18 closing price
Capitalization
2.77B
10 days until earnings call
Interact to see
Advertisement

CNMD vs IART

Header iconCNMD vs IART Comparison
Open Charts CNMD vs IARTBanner chart's image
CONMED
Price$47.64
Change-$1.61 (-3.27%)
Volume$476.41K
Capitalization2.43B
Integra LifeSciences Holdings
Price$11.13
Change-$0.85 (-7.10%)
Volume$973.58K
Capitalization2.77B
CNMD vs IART Comparison Chart in %
Loading...
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNMD vs. IART commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Hold and IART is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CNMD: $47.64 vs. IART: $11.13)
Brand notoriety: CNMD and IART are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CNMD: 130% vs. IART: 85%
Market capitalization -- CNMD: $2.43B vs. IART: $2.77B
CNMD [@Medical Specialties] is valued at $2.43B. IART’s [@Medical Specialties] market capitalization is $2.77B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNMD’s FA Score shows that 1 FA rating(s) are green whileIART’s FA Score has 1 green FA rating(s).

  • CNMD’s FA Score: 1 green, 4 red.
  • IART’s FA Score: 1 green, 4 red.
According to our system of comparison, CNMD is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNMD’s TA Score shows that 4 TA indicator(s) are bullish while IART’s TA Score has 2 bullish TA indicator(s).

  • CNMD’s TA Score: 4 bullish, 6 bearish.
  • IART’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CNMD is a better buy in the short-term than IART.

Price Growth

CNMD (@Medical Specialties) experienced а -7.08% price change this week, while IART (@Medical Specialties) price change was -11.60% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

CNMD is expected to report earnings on Jul 30, 2025.

IART is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($2.77B) has a higher market cap than CNMD($2.43B). IART has higher P/E ratio than CNMD: IART (41.30) vs CNMD (38.71). CNMD YTD gains are higher at: -29.898 vs. IART (-50.926). IART has higher annual earnings (EBITDA): 256M vs. CNMD (192M). IART has more cash in the bank: 309M vs. CNMD (24.3M). CNMD has less debt than IART: CNMD (974M) vs IART (1.68B). IART has higher revenues than CNMD: IART (1.54B) vs CNMD (1.25B).
CNMDIARTCNMD / IART
Capitalization2.43B2.77B88%
EBITDA192M256M75%
Gain YTD-29.898-50.92659%
P/E Ratio38.7141.3094%
Revenue1.25B1.54B81%
Total Cash24.3M309M8%
Total Debt974M1.68B58%
FUNDAMENTALS RATINGS
CNMD vs IART: Fundamental Ratings
CNMD
IART
OUTLOOK RATING
1..100
5013
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6090
PRICE GROWTH RATING
1..100
8592
P/E GROWTH RATING
1..100
968
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNMD's Valuation (8) in the Medical Specialties industry is significantly better than the same rating for IART (80). This means that CNMD’s stock grew significantly faster than IART’s over the last 12 months.

CNMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IART (100). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.

CNMD's SMR Rating (60) in the Medical Specialties industry is in the same range as IART (90). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.

CNMD's Price Growth Rating (85) in the Medical Specialties industry is in the same range as IART (92). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.

IART's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for CNMD (96). This means that IART’s stock grew significantly faster than CNMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNMDIART
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
57%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
73%
MACD
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 12 days ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHTCX43.060.11
+0.26%
Columbia Seligman Global Tech C
JVLCX22.930.02
+0.09%
JHancock Disciplined Value C
HGXFX16.76N/A
N/A
Hartford Global Impact F
GSSMX34.37-0.15
-0.43%
Goldman Sachs Small Cap Value A
WWSCX16.70-0.10
-0.60%
Keeley Small Cap Fund C

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
-3.27%
NVST - CNMD
52%
Loosely correlated
-1.22%
SHC - CNMD
49%
Loosely correlated
-1.51%
RVTY - CNMD
48%
Loosely correlated
-2.36%
AZTA - CNMD
47%
Loosely correlated
-2.96%
A - CNMD
45%
Loosely correlated
-2.04%
More

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ZBH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ZBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
-7.10%
ZBH - IART
44%
Loosely correlated
-1.80%
TMCI - IART
44%
Loosely correlated
-2.42%
AZTA - IART
43%
Loosely correlated
-2.96%
ITGR - IART
42%
Loosely correlated
-1.88%
CNMD - IART
41%
Loosely correlated
-3.27%
More